Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
$0.50
-5.4%
$1.06
$3.01
$13.40
$2.03M-0.0822,626 shs240,714 shs
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$0.31
+8.9%
$0.27
$0.23
$2.23
$10.86M0.515.37 million shs1.10 million shs
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
$2.02
+3.1%
$2.15
$1.57
$11.16
$6.47M3.21119,059 shs49,551 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$3.26
-1.8%
$3.02
$1.71
$8.60
$9.16M0.6550,022 shs21,405 shs
10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
+0.15%-12.19%-49.97%-53.07%-95.09%
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-2.93%+8.38%-0.56%+17.12%-80.43%
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
+2.08%-2.00%-10.09%-29.50%-46.74%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
+0.91%+7.79%+19.42%+18.15%-23.15%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
4.4965 of 5 stars
3.55.00.04.42.80.01.3
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
0.8696 of 5 stars
0.04.00.00.02.70.00.6
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
2.4925 of 5 stars
3.54.00.00.01.61.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
0.00
N/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
3.00
Buy$5.501,692.11% Upside
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
0.00
N/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
3.00
Buy$28.00758.90% Upside

Current Analyst Ratings Breakdown

Latest BLAC, LUCY, CODX, and SINT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/15/2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$10.00
5/30/2025
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$30.00 ➝ $28.00
(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$3.91M3.02N/AN/A$1.07 per share0.29
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
$1.64M4.06N/AN/A$3.42 per share0.59
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$2.89M3.11N/AN/A$1.45 per share2.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$37.64M-$1.15N/AN/AN/A-3,588.33%-69.49%-60.49%11/6/2025 (Estimated)
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
-$7.77M-$2.78N/AN/A-390.70%-79.72%-74.86%N/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$11.02M-$50.56N/AN/A-674.05%-256.59%-121.32%N/A

Latest BLAC, LUCY, CODX, and SINT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$0.25-$0.23+$0.02-$0.23$0.30 million$0.16 million
8/14/2025Q2 2025
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
-$0.77-$0.66+$0.11-$0.66$1.00 million$0.58 million
8/14/2025Q2 2025
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$0.79-$0.91-$0.12-$0.91$0.40 million$0.15 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/AN/AN/AN/AN/A
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/A
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/A
4.12
4.23
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
N/A
18.70
13.02
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A
2.57
3.25

Institutional Ownership

CompanyInstitutional Ownership
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
55.30%
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
14.99%
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
0.96%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
18.38%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/A4.04 million2.68 millionNot Optionable
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
10038.52 million35.29 millionOptionable
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
93.30 million3.24 millionNot Optionable
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
402.76 million2.65 millionNot Optionable

Recent News About These Companies

Sintx Technologies, Inc. (SINT) - Yahoo Finance
SiNtx Technologies Inc.
SiNtx Technologies Inc.
Sintx Technologies announces changes to board, Chairman Bal to retire

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bellevue Life Sciences Acquisition stock logo

Bellevue Life Sciences Acquisition NASDAQ:BLAC

$0.50 -0.03 (-5.45%)
As of 08/20/2025

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Co-Diagnostics stock logo

Co-Diagnostics NASDAQ:CODX

$0.31 +0.03 (+8.91%)
Closing price 04:00 PM Eastern
Extended Trading
$0.30 -0.01 (-3.23%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Innovative Eyewear stock logo

Innovative Eyewear NASDAQ:LUCY

$2.02 +0.06 (+3.06%)
Closing price 04:00 PM Eastern
Extended Trading
$1.96 -0.06 (-2.97%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

Sintx Technologies stock logo

Sintx Technologies NASDAQ:SINT

$3.26 -0.06 (-1.81%)
Closing price 04:00 PM Eastern
Extended Trading
$3.19 -0.07 (-2.27%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.